Strattera Liver Risk Subject Of U.K. Letter To Physicians
This article was originally published in The Pink Sheet Daily
Executive Summary
Because "the risk is estimated at below 1 in 50,000" and the occurrences appear idiosyncratic, "routine monitoring is unlikely to be helpful," the letter states. Lilly added a bolded warning to U.S. labeling in December concerning the risk.